Choose Language
Select a language for news translation.
Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer's top healthcare stocks even though the shares have been lackluster. They are up by a modest…
Despite tremors in its share price, Cramer continues to be lukewarm about Meta Platforms (NASDAQ:META). The shares are down by 8.5% year-to-date and by 16.7% o…
Jim Cramer highlighted IBM CEO Arvind Krishna's admission of the company's failure to adapt quickly to changing market demands, which contributed to a signific…
In his Tuesday appearance on Squawk on the Street, Jim Cramer continued to assert that Wells Fargo & Company (NYSE: WFC )'s multiple was too low. Throughout th…
Novo Nordisk A/S (NYSE: NVO ) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday. The firm claimed that Li…
